Garrison Pharma (India) Limited
About Garrison Pharma (India) Limited
Data last updated:
Garrison Pharma (India) Limited is a public limited company based in Daman, Daman And Diu, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 22 October 1993 and has been in existence for over 33 years.
The company is registered with the Registrar of Companies (ROC), Goa, under CIN U24232DD1993PLC001459. The company has 2 GST registrations on record, none of which is active.
The company has an authorised share capital of ₹2 Cr and a paid-up capital of ₹2 Cr. It is led by directors including Kavita Sagar Sule and Sagar Sule.
Its last annual general meeting (AGM) was held on 30 September 2009, and its latest financial statements are for the year ended 31 March 2009. The registered office is at 2/182 Vaniawad Nani Daman, Daman and Diu, India – 396210.
As per MCA filings, the company has open charges of ₹2.15 Cr on record. Court records list 19 cases involving the company, including 2 filed by the company and 17 filed against it; 12 cases are pending.
The current compliance status is marked as active non-compliant by the Registrar of Companies.
Company details
CIN history
Garrison Pharma (India) has one previous CIN (Corporate Identification Number): U24232DD1993PTC001459. The current CIN is U24232DD1993PLC001459, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U24232DD1993PLC001459 | Current |
| U24232DD1993PTC001459 | Previous |
Contact details
Garrison Pharma (India) Limited's registered office is in Daman, Daman And Diu.
- Registered Address2/182 Vaniawad Nani Daman, Daman and Diu, India – 396210
- IndustryPharma, Drug Formulation & Development
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Financials of Garrison Pharma (India) Limited
FY 2009 filings availableFinancial Statement Summary
| Metrics | FY 2008-09 |
|---|---|
| Profit and Loss Statement | |
| Revenue from Operations | |
| Other Income | |
| Total Revenue | |
| Cost of Materials Consumed | |
| Employee Benefit Expense | |
| Finance Costs | |
| Depreciation and Amortisation | |
| Other Expenses | |
| Total Expenses | |
| EBITDA | |
| Profit Before Tax | |
| Tax Expense | |
| Net Profit (PAT) | |
| Balance Sheet | |
| Share Capital | |
| Reserves and Surplus | |
| Net Worth (Total Equity) | |
| Long-term Borrowings | |
| Short-term Borrowings | |
| Trade Payables | |
| Total Liabilities | |
| Fixed Assets | |
| Investments | |
| Inventories | |
| Trade Receivables | |
| Cash and Bank Balance | |
| Total Assets | |
Financial Ratios
| Metrics | FY 2008-09 |
|---|---|
| Profitability | |
| EBITDA Margin | |
| Net Profit Margin | |
| Return on Equity (ROE) | |
| Return on Capital Employed (ROCE) | |
| Return on Assets (ROA) | |
| Liquidity and Debt | |
| Current Ratio | |
| Quick Ratio | |
| Debt-to-Equity Ratio | |
| Interest Coverage Ratio | |
| Efficiency and Growth | |
| Asset Turnover | |
| Receivable Days | |
| Payable Days | |
| Inventory Days | |
| Revenue Growth | |
| Net Profit Growth | |
To see the full financial statements and ratios of Garrison Pharma (India) Limited, buy the company report.
Board of directors of Garrison Pharma (India) Limited
Garrison Pharma (India) has 3 current directors and 10 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Kavita Sagar Sule | Director | 25 May 2019 | 7 Years 5 Months | Current |
| Sagar Sule | Director | 25 May 2019 | 7 Years 5 Months | Current |
| Bhavish Sudhir Rao Also directs: Sage Seafoods Private Limited | Director | 25 May 2019 | 7 Years 5 Months | Current |
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 13 Apr 2006 | 10289449 | Ratnakar Bank Ltd | ₹25 Lakh | Open | |
| 13 Apr 2006 | 10289450 | Ratnakar Bank | ₹50 Lakh | Open | |
| 21 Sep 2004 | 90384110 | Corporation Bank | ₹15 Lakh | Open | |
| 29 Jun 1991 | 90383801 | Canara Bank | ₹1.25 Cr | Open |
To see the full charge records of Garrison Pharma (India) Limited, buy the company report.
Total charge records: 4 View all charges
Legal cases
Garrison Pharma (India) Limited has 19 court cases on record: 2 filed by Garrison Pharma (India), 17 filed against it. 12 cases are pending and 7 are disposed.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 16 | 16 | 12 |
| High courts | 3 | 1 | 0 |
Cases on record (5 of 19)
| Court | Type of case | Party | Status |
|---|---|---|---|
| Bombay High Court | Court case (EXA) | Filed against the company by M/S Kotak Mahindra Prime Ltd. (Formerly Kotak Mahindra Primus Ltd.) and 1 other | Disposed |
| District court, North Goa, Goa | Court case (AOA) | Filed against the company by The Registrar of Companies | Pending |
| District court, North Goa, Goa | Court case (AOA) | Filed against the company by Office of the Registrar of Companies | Pending |
| District court, North Goa, Goa | Court case (LC) | Filed against the company by Government of India | Pending |
| District court, North Goa, Goa | Court case (LC) | Filed against the company by an individual | Pending |
To see the full case history of Garrison Pharma (India) Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Garrison Pharma (India) Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Garrison Pharma (India) has 2 GST registrations on record, and all of them have been cancelled or are inactive. Only active GST numbers are listed on this page.
To see the full GST registrations and return filing status of Garrison Pharma (India) Limited, buy the company report.
Recent activity
Garrison Pharma (India) Limited has 13 board changes on record since 2013: 3 appointments and 10 cessations. The latest: Bhavish Sudhir Rao was appointed as Director on 25 May 2019.
9 earlier events are in the company report.
Frequently asked questions
Garrison Pharma (India) is an active public limited company based in Daman, Daman And Diu, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 22 October 1993 (33+ years old) and is registered under CIN U24232DD1993PLC001459.
Garrison Pharma (India) has 3 current directors:
- Kavita Sagar Sule - Director
- Sagar Sule - Director
- Bhavish Sudhir Rao - Director
The latest financial statements of Garrison Pharma (India) on record with the MCA are for the year ended 31 March 2009. Its last annual general meeting was held on 30 September 2009. Year-wise statements from 2015 are in the company report.
No. Garrison Pharma (India) has 2 GST registrations on record and all of them are cancelled or inactive.
The CIN (Corporate Identification Number) of Garrison Pharma (India) is U24232DD1993PLC001459. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Garrison Pharma (India) has 19 court cases on record: 2 filed by the company and 17 filed against it. 12 are pending. Most are in the district courts.
Garrison Pharma (India) was incorporated on 22 October 1993, making it 33+ years old. It is registered with the Registrar of Companies, Goa.
Bhavish Sudhir Rao was appointed as Director on 25 May 2019. Dinesh Babulal Shah ceased to be Managing Director on 25 May 2019. Kavita Sagar Sule was appointed as Director on 25 May 2019. Garrison Pharma (India) has 13 board changes on record in total.
The registered office of Garrison Pharma (India) is at 2182 Vaniawad Nani Daman, Daman and Diu, India – 396210.
Garrison Pharma (India) operates in the pharma industry, in the drug formulation and development segment.